Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private

BSE2145.6531.8 (+1.5 %)

PREV CLOSE ( ) 2113.85

OPEN PRICE ( ) 2111.80

BID PRICE (QTY) 2140.80 (4)

OFFER PRICE (QTY) 2142.85 (2)

VOLUME 2253

TODAY'S LOW / HIGH ( )2111.80 2185.35

52 WK LOW / HIGH ( )1551.05 2636

NSE2140.3023.3 (+1.1 %)

PREV CLOSE( ) 2117.00

OPEN PRICE ( ) 2117.00

BID PRICE (QTY) 2140.40 (1)

OFFER PRICE (QTY) 2142.60 (7)

VOLUME 32607

TODAY'S LOW / HIGH( ) 2111.10 2185.00

52 WK LOW / HIGH ( )1599 2641

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1990

Management Info

C C Paarthipan - Chairman Sridhar Ganesan - Managing Director

Registered Office

Address 3rd Floor, “ Ashvich Towers”,No.3, Developed Plots Industrial Estate,Perungudi,
Chennai,
Tamil Nadu-600096

Phone 044-24968000 / 8012772888 / 71148000

Email info@caplinpoint.net

Website www.caplinpoint.net

Registrars Details

Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai

Listing : BSE, NSE

NEWS

03Sep Caplin Point’s arm gets USFDA’s final
Caplin Point Laboratories’ subsidiary -- Caplin Steriles has been grante..

03Sep Caplin Point Laboratories informs abou
Caplin Point Laboratories has informed that it enclosed a Press Release..

08Aug Caplin Point Laboratories gains on rep
Caplin Point Laboratories is currently trading at Rs 2070.85, up by 13.4..

07Aug Caplin Point Laboratories reports 23%
Caplin Point Laboratories has reported result for first quarter ended Ju..

30Jul Caplin Point Laboratories informs abou
Caplin Point Laboratories has informed that a post-results conference ca..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	858.9	3394.9
Gross Profit	1124.6	4416.7
Operating Profit	1186.4	4665.6
Net Sales	1825.7	7524.1

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 14788.80 (1.25%)	M.Cap ( in Cr)18962.19
Astrazeneca Pharma I (BSE) 9152.90 (0.70%)	M.Cap ( in Cr)22875.00
Glenmark Pharma (BSE) 2050.05 (2.99%)	M.Cap ( in Cr)57879.39
Acutaas Chemicals (BSE) 1480.75 (3.89%)	M.Cap ( in Cr)12135.02
Hester Biosciences (BSE) 2142.05 (2.16%)	M.Cap ( in Cr)1831.06

Shareholding Pattern

	PROMOTERS	70.56%
	NON-INSTITUTION	21.05%
	MUTUAL FUNDS/UTI	1.93%
	FI/BANKS/INSURANCE	0.22%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Samco Flexi Cap Fun...	6.31
Samco ELSS Tax Save...	2.79
UTI Healthcare Fund...	2.73
UTI Small Cap Fund-Reg(G)	1.53
DSP Nifty Smallcap2...	1.48
Samco Multi Cap Fun...	1.22
ITI Pharma & Health...	1.02

Risk Disclosures on Derivatives

Smart Quotes

CAPLIN POINT LABORATORIES LTD.